These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2557972)

  • 1. [Antibiotic resistance plasmids from Serratia marcescens and their elimination by DNA-gyrase inhibitors].
    Llanes C; Michel-Briand Y; Couturier M; Thouverez M; Bailly C
    C R Seances Soc Biol Fil; 1989; 183(3):240-6. PubMed ID: 2557972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of conjugative and non-conjugative R-plasmids from Serratia marcescens to gyrase inhibitors.
    Llanes C; Michel-Briand Y; Thouverez M; Bailly C; Grimont F
    Microbiologica; 1990 Apr; 13(2):157-9. PubMed ID: 2161994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-transmissible and self-transmissible plasmids conferring drug resistance in clinical isolates of Serratia marcescens from hospitals in Riyadh, Saudi Arabia.
    al-Harithy RN; al-Ssum R
    New Microbiol; 1993 Jan; 16(1):63-71. PubMed ID: 8469172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid prevalence in antibiotic resistant Serratia marcescens.
    Llanes C; Michel-Briand Y; Bailly C; Grimont F
    J Chemother; 1989 Jul; 1(4 Suppl):311-2. PubMed ID: 16312416
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transmissible formaldehyde resistance in Serratia marcescens].
    Kaulfers PM; Laufs R
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Dec; 181(3-5):309-19. PubMed ID: 3938144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
    Masecar BL; Robillard NJ
    Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of an efflux pump in Serratia marcescens.
    Berlanga M; Vázquez JL; Hernandez-Borrell J; Montero MT; Viñas M
    Microb Drug Resist; 2000; 6(2):111-7. PubMed ID: 10990265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effect of ciprofloxacin on plasmid-mediated resistance.
    Mehtar S; Blakemore PH; Ellis K
    Chemioterapia; 1987 Jun; 6(2 Suppl):210-1. PubMed ID: 3334559
    [No Abstract]   [Full Text] [Related]  

  • 10. Chromosomal origin of acetyltransferase AAC(6') specifying amikacin resistance in Serratia marcescens.
    Gómez-Lus R; Rivera MJ; Bobey D; Martín C; Navarro M
    Microbiologia; 1987 Oct; 3(3):185-94. PubMed ID: 3077328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of carbapenem resistant plasmid isolated from Serratia marcescens].
    Yosue T
    Fukuoka Igaku Zasshi; 1996 May; 87(5):116-26. PubMed ID: 8690335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A relationship between R plasmids and increased incidence of nonpigmenting drug-resistant Serratia marcescens from clinical sources].
    Muto Y; Tsuji A; Kaneko Y; Goto S
    Nihon Saikingaku Zasshi; 1982 Nov; 37(6):931-7. PubMed ID: 6763638
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of and resistance to ciprofloxacin.
    Hooper DC; Wolfson JS; Ng EY; Swartz MN
    Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of drug-resistance plasmids by conjugation from nosocomial strains of Serratia marcescens to Escherichia coli in biological fluids of human origin.
    Mendez FJ; Mendoza MC; Llaneza JJ; Hardisson C
    J Hosp Infect; 1982 Sep; 3(3):285-92. PubMed ID: 6183321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth depression of Serratia marcescens by plasmids that belong to incompatibility group P.
    Platt DJ; Chesham JS
    Microbios; 1990; 63(256-257):151-7. PubMed ID: 2172750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of a gentamicin resistance plasmid in the microbial population of hospital patients.
    Falbo V; Passi C; Caprioli A; Romoli E; Di Leonardo F
    Microbiologica; 1986 Jul; 9(3):353-65. PubMed ID: 3018453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R
    J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and epidemiologic study of multiresistant Serratia marcescens infections in a spinal cord injury rehabilitation unit.
    Simor AE; Ramage L; Wilcox L; Bull SB; Bialkowska-Hobrzanska H
    Infect Control; 1988 Jan; 9(1):20-7. PubMed ID: 3276639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.